Safety and Efficacy Study of Gamaline+Hipericin in PMS

NCT01283568 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2011-11-29

No results posted yet for this study

Summary

GAMALINE is already register for PMS and HIPERICIN as antidepressive drug. Both plant extracts. The investigators will try the mixture and see if the vasomotor symptoms will disappear. The investigators expect that together all symptoms will be covered better than Gamaline alone. The investigators will run for 180 days measuring at T0, T1 and T6 (starting point, 30 days and 180 days).

Conditions

Sponsors & Collaborators

  • Herbarium Laboratorio Botanico Ltda

    collaborator INDUSTRY
  • Federal University of Health Science of Porto Alegre

    collaborator OTHER
  • Phytopharm Consulting Brazil

    lead NETWORK

Principal Investigators

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-12-31
Completion
2012-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01283568 on ClinicalTrials.gov